For the Inventor, By the Inventor

Enter assignee name

Oxford, United Kingdom

British Biotech Pharmaceuticals Limited

USPTO Granted Patents = 85

% Expired Patents = 14.1

Forward Citations = 426

Loading Chart...

Loading Chart...

56 inventors (with patents filed for the assignee):

Mark Whittaker (44 out of 53 patents)

Raymond Paul Beckett (34 out of 38 patents)

Andrew Miller (26 out of 32 patents)

4. Fionna Mitchell Martin (15 out of 15 patents)

5. Zoe Marie Spavold (14 out of 15 patents)

6. Michael George Hunter (13 out of 17 patents)

7. John Martin Clements (10 out of 10 patents)

8. Lisa Marie Pratt (9 out of 9 patents)

9. Michael John Crimmin (9 out of 14 patents)

10. Andrew Paul Ayscough (8 out of 8 patents)

11. Stephen Arthur Bowles (8 out of 12 patents)

12. Steven Launchbury (7 out of 7 patents)

13. Richard Mark Edwards (7 out of 12 patents)

14. Christopher David Floyd (7 out of 7 patents)

15. Christopher Norman Lewis (6 out of 8 patents)

Core Competencies:

Antibacterial Agents

Hydroxamic Acid Derivatives

Metalloproteinase Inhibitors

Cytostatic Agents

Anti-Inflammatory Agents

Synthetic Derivatives

Stem Cell Inhibiting Proteins

Chimeric Virus-Like Particles

Dioxolane Intermediates

Thrombolytic Composition

Disaccharide Ligands

Natural Amino Acid Derivatives

85 patents: Sort by Forward Citations

1. 7323563 - Hydroxamic acid derivatives as antibacterials (2008-01-29),

2. 7323448 - Antibacterial agents (2008-01-29),

3. 7186719 - Antibacterial agents (2007-03-06),

4. 7173053 - N-formyl hydroxylamine derivatives as inhibitors of bacterial polypeptide formylase for treating microbial infections (2007-02-06),

5. 7148198 - Antibacterial agents (2006-12-12),

6. 6992190 - Hydroxamic acid derivatives as antibacterials (2006-01-31),

7. 6908911 - Antibacterial agents (2005-06-21),

8. 6846825 - Antibacterial agents (2005-01-25),

9. 6790834 - Cytostatic agents (2004-09-14),

10. 6787522 - Antibacterial agents (2004-09-07),

11. 6545051 - Antibacterial hydroxamic acid derivatives (2003-04-08),

12. 6503897 - Antibacterial agents (2003-01-07),

13. 6495597 - Cytostatic agents (2002-12-17),

14. 6479502 - Hydroxamic acid derivatives as proteinase inhibitors (2002-11-12),

15. 6462023 - Cytostatic agents (2002-10-08),

Company Overview

British Biotech Pharmaceuticals Limited, based in Oxford, specializes in the development of innovative therapeutics focusing on metalloproteinase inhibitors. The company is engaged in research and production of various agents, including antibacterial compounds, hydroxamic acid derivatives, and cytostatic agents. Their work extends to anti-inflammatory agents and synthetic derivatives, with a notable emphasis on stem cell inhibiting proteins and chimeric virus-like particles, positioning them at the forefront of biopharmaceutical advancements.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

85 Patents

#6 in Oxford

#214 in United Kingdom

#8,962 in the World

Oxford, United Kingdom

British Biotech Pharmaceuticals Limited

Forward Citations = 426

56 inventors:

Mark Whittaker (44 out of 53 patents)

Raymond Paul Beckett (34 out of 38 patents)

Andrew Miller (26 out of 32 patents)

4. Fionna Mitchell Martin (15 out of 15 patents)

5. Zoe Marie Spavold (14 out of 15 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: British Biotech Pharmaceuticals Limited. Retrieved from https://idiyas.com/company/british-biotech-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…